Ian Hickson
Impact in
- Oncology top 0.5%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
Papers in
-
- DNA Repair Mechanisms 14
- Ubiquitin and proteasome pathways 4
- Histone Deacetylase Inhibitors Research 3
- Genomics and Chromatin Dynamics 3
- Oncology 9
- Cancer-related Molecular Pathways 4
- Co-authors
- Niall M.B. Martin (5 shared papers)Graeme C.M. Smith (4 shared papers)Stephen P. Jackson (2 shared papers)Alan Ashworth (1 shared paper)Charlotte Knights (1 shared paper)Damian A. Johnson (1 shared paper)Andrew Tutt (1 shared paper)Hannah Farmer (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (3 papers)Cancer Research (3 papers)Neuro-Oncology (2 papers)Gene Therapy (2 papers)Molecular Cell (1 paper)
- Partner nations
- United KingdomUnited StatesBelgium
In The Last Decade
Ian Hickson
28 papers receiving 6.4k citations
Ian Hickson's Hit Papers
Peers
Comparison fields: 5 of 105
- Oncology 4.0k
- Cancer Research 898
- Molecular Biology 4.4k
- Reproductive Medicine 325
- Genetics 835
Countries citing papers authored by Ian Hickson
This map shows the geographic impact of Ian Hickson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Hickson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Hickson more than expected).
Fields of papers citing papers by Ian Hickson
This network shows the impact of papers produced by Ian Hickson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Hickson. The network helps show where Ian Hickson may publish in the future.
Co-authors
The 25 scholars most cited alongside Ian Hickson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy Hit paper breakdown → | 2005 | 4810 |
| 2 | Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM Hit paper breakdown → | 2004 | 985 |
| 3 | 2013 | 170 | |
| 4 | 2007 | 62 | |
| 5 | 1997 | 51 | |
| 6 | 2009 | 51 | |
| 7 | 2014 | 44 | |
| 8 | 1998 | 38 | |
| 9 | 2013 | 38 | |
| 10 | 2022 | 31 | |
| 11 | 1996 | 29 | |
| 12 | 1998 | 27 | |
| 13 | 2014 | 27 | |
| 14 | 2021 | 22 | |
| 15 | 2021 | 20 | |
| 16 | 1999 | 18 | |
| 17 | 2022 | 17 | |
| 18 | 2018 | 12 | |
| 19 | 1997 | 8 | |
| 20 | 2016 | 7 |
About Ian Hickson
Ian Hickson is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Genetics, having authored 29 papers that have together received 6.5k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (14 papers), Prostate Cancer Treatment and Research (5 papers), Ubiquitin and proteasome pathways (4 papers), Cancer-related Molecular Pathways (4 papers), Carcinogens and Genotoxicity Assessment (4 papers), Cancer, Lipids, and Metabolism (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Genomics and Chromatin Dynamics (3 papers). The work is most often cited by research in Oncology (4.0k citations), Cancer Research (898 citations), Molecular Biology (4.4k citations), Reproductive Medicine (325 citations) and Genetics (835 citations). Ian Hickson has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include Niall M.B. Martin, Graeme C.M. Smith, Stephen P. Jackson, Alan Ashworth, Charlotte Knights, Damian A. Johnson, Andrew Tutt, Hannah Farmer, Christopher J. Lord and Nuala McCabe. Their work appears in journals such as Journal of Medicinal Chemistry, Cancer Research, Neuro-Oncology, Gene Therapy and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.